ASCO collage 2024

A Journey of Collaborations

June 25, 2024

We at the RTFCCR are thrilled to share the exciting progress made during our recent attendance at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, from May 30th to June 4th. Our booth was a hub of activity, attracting numerous visitors, including distinguished physicians, passionate patient advocates, and numerous key stakeholders. The highlight of this event was receiving the prestigious Top Donor Award from Conquer Cancer, the ASCO Foundation, a testament to our commitment and collective efforts in the fight against cancer. 

The momentum continued as our team visited some of the most esteemed institutions in the field. During our visits to the MD Anderson Cancer Center, Massachusetts General Hospital, and Dana-Farber Cancer Institute we engaged in meaningful dialogues and strengthened partnerships that are crucial to our mission. 

Highlights from site visits 

At the Massachusetts General Hospital, we conducted a series of strategic meetings with several departments and their leaders, including the Cancer Outcome Research and Education Program (CORE) and the Directors of Pediatric, Surgery, and Radiation Oncology. Discussions with the Physician-In-Chief of Hematology Oncology and the Vice Chair of Research provided valuable insights into the hospital’s cutting-edge medical research. Additionally, the team had the opportunity to engage with Dr. Torunn Yock, a current grantee whose work exemplifies the innovative spirit that drives progress in medical science. This visit underscores our that can lead to breakthroughs in healthcare. 

During the visit to the Dana-Farber Cancer Institute, many engagements with the institute’s leaders took place, including the Director and Medical Oncology Representatives, which offered insights into new therapeutic strategies. The Gynecologic Oncology Chair discussed novel treatment methods, while Pediatric Oncology and Early Detection teams demonstrated their commitment to early-stage cancer care. The Global Health and Equity Cancer Center Director emphasized international cooperation in cancer research. Overall, the visit highlighted the institute’s pivotal role in cancer treatment innovation and global health advancement. 

During the visit to MD Anderson Cancer Center, seven grantees reported on projects supported by our foundation. A subsequent tour of LBJ Hospital, a local hospital dedicated to the underserved community and a site visit of one of our grantees, highlighted the real-world benefits of our funding. Outreach efforts included a presentation to the Pain Consortium, effectively spreading the RTFCCR Chronic Cancer Pain Research call for proposals. Meetings with Dr. Chung and VPs Andrew Dennis and Phil Jones explored potential collaborations, reflecting our dedication to advancing medical innovation and strategic partnerships. 

Each visit was marked by the exchange of groundbreaking ideas and the strengthening of connections that are vital to our mission. 

We extend our deepest gratitude to everyone who engaged with us, shared insights, and contributed to the success of this journey. Your support is the driving force behind our continued dedication to making a significant impact in cancer care and research. Together, we are forging a path toward a future where cancer can be conquered.  

Thank you for being an integral part of our story. 



Scroll to Top